Evidence map›Paper›PMID 40555562›Full record

ArticleJournal for immunotherapy of cancer2025

Ectopic expression of GDF15 in cancer-associated fibroblasts enhances melanoma immunosuppression via the GFRAL/RET cascade.

Zhijie Zhao, Huabao Cai, Wenyang Nie, Xiaojing Wang, Zhenzhen Zhao, Fu Zhao, Yisheng Chen, Zhiwen Luo, Zhiheng Lin, Li Lin and 1 more

Abstract read
In one paragraph

Article in Journal for immunotherapy of cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Cytokines and cancer-associated fibroblasts.Journal of hematology & oncology · 2026
    Review
  5. SENP3 drives colorectal cancer progression by enhancing GDF15 expression.International journal of colorectal disease · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Integrative single-cell analysis revealsFrontiers in immunology · 2026
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Zhijie ZhaoDepartment of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, School of Medicine, Shanghai JiaoTong University, Shanghai, China.ORCID http://orcid.org/0000-0001-5587-8855
Huabao CaiDepartment of Neurosurgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Wenyang NieThe First Clinical Medical College of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
Xiaojing WangDepartment of Rheumatology and Immunology, Tongren Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Zhenzhen ZhaoThe First Clinical Medical College of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
Fu ZhaoSchool of Traditional Chinese Medicine, Jinan University, Guangzhou, Guangdong, China.
Yisheng ChenFujian Key Laboratory of Toxicant and Drug Toxicology, Medical College, Ningde Normal University, Ningde, Fujian, China.
Zhiwen LuoDepartment of Sport Medicine, Huashan Hospital, Fudan University, Shanghai, China.
Zhiheng LinDepartment of Gynecology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Li LinDepartment of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, School of Medicine, Shanghai JiaoTong University, Shanghai, China yantaoding@ahmu.edu.cn linli991@alumni.sjtu.edu.cn.
Yantao DingDepartment of Dermatology, The First Affiliated Hospital, Anhui, Medical University, Hefei, Anhui, China yantaoding@ahmu.edu.cn linli991@alumni.sjtu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA key aspect of tumor biology is the involvement of cancer-associated fibroblasts (CAFs) in shaping the immunosuppressive microenvironment. However, the dynamic and complex key roles of CAFs in the melanoma immune microenvironment have not been elucidated.

methodsThe CAFs landscape in melanoma was characterized using single-cell RNA-seq and spatial transcriptomics. Molecular dynamics simulations were employed to validate the interactions between CAFs and melanoma cells. Bulk RNA-seq was used to establish a prognostic model. To validate the expression of key targets, western blotting, quantitative real-time PCR, and ELISA were performed. The molecular interactions were confirmed via co-immunoprecipitation, chromatin immunoprecipitation, and luciferase gene reporter assays. In-depth molecular mechanisms were explored using lentiviral transfection, cell co-culture experiments, recombinant protein rescue experiments, flow cytometry, knockout mice, and Cre-loxP system mice.

resultsThis study identified a unique group of CAFs expressing high levels of growth differentiation factor 15 (GDF15). The paracrine secretion of GDF15 was regulated by the transcription factor FOXP1, which subsequently binds to the TGFBR2 receptor on melanoma cells, driving their proliferation and metastatic capacity. In addition, CAFs-derived GDF15 interacts with the GFRAL receptor on melanoma cells, thereby promoting RET phosphorylation and triggering downstream signaling axes, inducing increased tumor cell stemness and secretion of inflammatory factors CCL18 and TGF-β. This cascade reaction ultimately induces macrophage polarization to the immunosuppressive M2 phenotype, assists in the establishment of an immunosuppressive microenvironment, and leads to accelerated melanoma lung metastasis.

conclusionBy integrating single-cell RNA-seq, spatial transcriptomics, bulk RNA-seq, molecular dynamics simulation and complete experimental design, this study comprehensively characterized that ectopic expression of CAFs-derived GDF15 can act as an accomplice in melanoma progression by inducing increased tumor cell stemness and macrophage M2 polarization, reshaping the immune landscape of melanoma, and providing new ideas and new targets for precision immunotherapy of melanoma.

Indexed as

Cancer-Associated FibroblastsGlial Cell Line-Derived Neurotrophic Factor ReceptorsGrowth Differentiation Factor 15MelanomaProto-Oncogene Proteins c-retAnimalsCell Line, TumorHumansMiceSignal TransductionTumor MicroenvironmentGDF15 protein, humanGlial Cell Line-Derived Neurotrophic Factor ReceptorsGrowth Differentiation Factor 15Proto-Oncogene Proteins c-retRET protein, humanBiomarkerImmunosuppressionMacrophagesMelanomaTumor microenvironment - TME

Identifiers

PMID40555562
PMCPMC12198796

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.